Schedule 13G ownership disclosure
Aptevo Therapeutics Inc (US) OLD
Common stock, par value $0.001 per share · CUSIP: 03835L405
Event date: 2025-06-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Mitchell P. Kopin
Shares: 0.00 · Class: 0.00%
- Daniel B. Asher
Shares: 0.00 · Class: 0.00%
- Intracoastal Capital LLC
Shares: 0.00 · Class: 0.00%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-057838
- Form type
- SCHEDULE 13G
- Filer
- Aptevo Therapeutics Inc.
- CIK
- CIK 1671584
- Filed
- Jun 25, 2025
- Reporting period
- Jun 18, 2025
- Description
- Schedule 13G beneficial ownership